| Code | Description | Claims | Beneficiaries | Total Paid |
|---|
| 99213 |
Office or other outpatient visit for the evaluation and management of an established patient, low complexity |
1,122 |
793 |
$53K |
| 99214 |
Office or other outpatient visit for the evaluation and management of an established patient, moderate complexity |
660 |
513 |
$50K |
| 87491 |
Infectious agent detection by nucleic acid; Chlamydia trachomatis, amplified probe |
746 |
284 |
$33K |
| 87591 |
Infectious agent detection by nucleic acid; Neisseria gonorrhoeae, amplified probe |
680 |
267 |
$30K |
| 87511 |
|
669 |
170 |
$30K |
| 87661 |
Infectious agent detection by nucleic acid; Trichomonas vaginalis, amplified probe |
985 |
321 |
$27K |
| 87798 |
Infectious agent detection by nucleic acid; not otherwise specified, amplified probe, each organism |
553 |
132 |
$13K |
| 0502F |
|
176 |
156 |
$8K |
| 99395 |
Periodic comprehensive preventive medicine reevaluation, established patient, 18-39 years |
85 |
77 |
$7K |
| 87389 |
Infectious agent antigen detection by immunoassay technique, HIV-1 antigen with HIV-1 and HIV-2 antibodies |
36 |
26 |
$3K |
| 87481 |
|
31 |
12 |
$1K |
| 86780 |
|
36 |
26 |
$620.72 |
| 87801 |
Infectious agent detection by nucleic acid; amplified probe, multiple organisms |
15 |
12 |
$589.68 |
| 87624 |
Infectious agent detection by nucleic acid; human papillomavirus (HPV), high-risk types |
19 |
16 |
$541.68 |
| 96127 |
|
29 |
26 |
$433.11 |
| 86803 |
|
17 |
12 |
$284.77 |
| 87340 |
|
17 |
12 |
$228.16 |
| 81025 |
|
44 |
38 |
$206.77 |
| 87210 |
|
19 |
13 |
$75.20 |